jejunal neuroendocrine tumor G1

Summary

jejunal neuroendocrine tumor G1 (MONDO:0006257) is a cancer. A subtype of small intestinal neuroendocrine tumor G1 — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	jejunal neuroendocrine tumor G1
Mondo ID	MONDO:0006257
EFO	EFO:1000308
NCIT	C6429
UMLS	C1334296
MedGen	235235
GARD	0024349
Anatomy (UBERON)	UBERON:0002115
Is cancer (heuristic)	yes

Also known as: carcinoid tumor of jejunum · carcinoid tumor of the jejunum · carcinoid tumour of jejunum · carcinoid tumour of the jejunum · grade 1 neuroendocrine neoplasm of jejunum · jejunal carcinoid tumor · jejunal carcinoid tumour · jejunal NET G1 · jejunum carcinoid tumor · jejunum carcinoid tumor (disease) · jejunum carcinoid tumour · jejunum carcinoid tumour (disease) · jejunum NET G1 · jejunum neuroendocrine neoplasm G1 · jejunum neuroendocrine tumor, well differentiated, low grade

Disease family

This is a subtype of small intestinal neuroendocrine tumor G1. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system neuroendocrine neoplasm › digestive system neuroendocrine tumor, grade 1/2 › small intestine neuroendocrine tumor, well differentiated, low or intermediate grade › small intestinal neuroendocrine tumor G1 › jejunal neuroendocrine tumor G1

Related subtypes (1): ileal neuroendocrine tumor G1

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.